2005
DOI: 10.1007/s00213-005-0144-y
|View full text |Cite
|
Sign up to set email alerts
|

Methylphenidate effects in attention deficit/hyperactivity disorder: electrodermal and ERP measures during a continuous performance task

Abstract: Stimulant medication ameliorated some of the dysfunctions in AD/HD children, which are reflected in behavioural and ERP measures. These results, in combination with general differences in electrodermal activity, support a hypo-arousal model of AD/HD, which can explain the action of MPH in these children.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

8
44
1
1

Year Published

2009
2009
2022
2022

Publication Types

Select...
8
2

Relationship

2
8

Authors

Journals

citations
Cited by 82 publications
(54 citation statements)
references
References 53 publications
8
44
1
1
Order By: Relevance
“…Children with AD/HDcom showed differences in P3 indicative of problems with cue orienting, and subsequent CNV differences indicating inefficient preparation for the upcoming stimulus, effects that were not present for an Oppositional Defiant Disorder (ODD) or co-morbid AD/HDcom and ODD group (Banaschewski et al, 2003). During a CPT, children with AD/HDcom were reported to show reduced frontal N1 and N2 amplitudes and parietal P2 and P3 amplitudes to target stimuli, indicating diminished evaluative and processing capabilities (Lawrence et al, 2005). Children aged 5-7 with AD/HD characteristics were reported to show an atypical Go-P3 effect suggesting deficient attentional resource allocation, and a difference in cue-P3 indicating impaired orienting (Spronk et al, 2008).…”
Section: Attentionmentioning
confidence: 98%
“…Children with AD/HDcom showed differences in P3 indicative of problems with cue orienting, and subsequent CNV differences indicating inefficient preparation for the upcoming stimulus, effects that were not present for an Oppositional Defiant Disorder (ODD) or co-morbid AD/HDcom and ODD group (Banaschewski et al, 2003). During a CPT, children with AD/HDcom were reported to show reduced frontal N1 and N2 amplitudes and parietal P2 and P3 amplitudes to target stimuli, indicating diminished evaluative and processing capabilities (Lawrence et al, 2005). Children aged 5-7 with AD/HD characteristics were reported to show an atypical Go-P3 effect suggesting deficient attentional resource allocation, and a difference in cue-P3 indicating impaired orienting (Spronk et al, 2008).…”
Section: Attentionmentioning
confidence: 98%
“…P300 has been used to track medication effects in children with AD/HD in other studies as well. For example, Lawrence et al (2005) recorded the P300 elicited by target stimuli in a visual CPT. A frontal shift in P300 observed in children with AD/HD was found to normalize following administration of methylphenidate.…”
Section: Attention-deficit/hyperactivity Disordermentioning
confidence: 99%
“…Explicit analyses of Go-P3 evoked by the CPT in ADHD are rare, but some instances of diminished amplitude in patients have been observed [70,72,88,89].…”
Section: Psychophysiological Characteristicsmentioning
confidence: 99%